The Trifunctional Antibody Catumaxomab (Anti-Epcam X Anti-Cd3) In Patients With Malignant Ascites: Immunomonitoring Results Of A Pivotal Phase Ii/Iii Study (Pooled Population)
JOURNAL OF CLINICAL ONCOLOGY(2010)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要